The disease caused by MDRB is increasing world wide. How to combat these killers of mankind is the big area of concern for both developed and developing countries. Develop more and more antibiotics, identify newer target sites and what not. But will that answer the problem. We have multi various antibiotics of different generations. But ability of the microbes to surpass them and to become MDRB is on steep increase. Adaptation and survival of the fittest apply even to microbes. Only way to win the battle with MDRB is evolution of disease resistance in humans. How that could be possible.
How the MDRB are forming. Is not the indiscriminate use of antibiotics contributed to the above. To contain and control the disease caused by MDRB, we need to reinvest our mind and understand what the antibiotics will do in general. The antibiotics will act against the pathogens and destroy them. Post elimination of the pathogen, the host’s immunity is the one takes charge in recovering the patient.
How does the pathogen cause infection in its victim. Yes, the primary opportunity to enter into the host’s system, the ability of the organism to cause disease or surpass the immune surveillance of the host and or due to the weak immunity of the host are the key primary events for any disease establishment in the host . The host with weak immunity becomes an easy prey to the pathogens. Immunity facilitates the disease when it is not protective or weak and immunity help in recovery once the pathogen is knocked out. If we keep immunity boosting as one of the aspects of every treatment and essentially when dealing with the diseases due to MDRB, we may able to challenge the MDRB more effectively. This cardinal principle is what followed in the school of ancient medicine. Immune modulators/boosting drugs needs to get integrated into the treatment regimen of all systems of medicine to keep the hope of disease free world, Dr Ranganathan said in an interview.